These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7548208)

  • 1. Properties of elongation factor-2 fragments obtained by partial proteolysis.
    Dumont-Miscopein A; Lavergne JP; Reboud JP
    Biochim Biophys Acta; 1995 Sep; 1263(3):221-7. PubMed ID: 7548208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of elongation factor-2 by multisite phosphorylation.
    Redpath NT; Price NT; Severinov KV; Proud CG
    Eur J Biochem; 1993 Apr; 213(2):689-99. PubMed ID: 8386634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GTP binding to elongation factor eEF-2 unmasks a tryptophan residue required for biological activity.
    Guillot D; Penin F; Di Pietro A; Sontag B; Lavergne JP; Reboud JP
    J Biol Chem; 1993 Oct; 268(28):20911-6. PubMed ID: 8407925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the phosphorylation sites in elongation factor-2 from rabbit reticulocytes.
    Price NT; Redpath NT; Severinov KV; Campbell DG; Russell JM; Proud CG
    FEBS Lett; 1991 May; 282(2):253-8. PubMed ID: 2037042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trp221 is involved in the protective effect of elongation factor eEF-2 on the ricin/alpha-sarcin site of the ribosome.
    Guillot D; Lavergne JP; Reboud JP
    J Biol Chem; 1993 Dec; 268(35):26082-4. PubMed ID: 8253723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O; Nilsson L
    Biochim Biophys Acta; 1985 Feb; 824(2):152-62. PubMed ID: 3970930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the major Mr 100,000 substrate for calmodulin-dependent protein kinase III in mammalian cells as elongation factor-2.
    Nairn AC; Palfrey HC
    J Biol Chem; 1987 Dec; 262(36):17299-303. PubMed ID: 3693353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of N-terminal 60-kDa fragment of elongation factor 2].
    Korotkov KV; Plotnikov AN; Motuz LP; Vasilenko KS; Semisotnov GV; Alakhov IuB
    Bioorg Khim; 1998 Mar; 24(3):171-4. PubMed ID: 9612557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structure-activity domain of elongation factor EF-2. Analysis of fragments of limited EF-2 hydrolysis, obtained using trypsin and elastase].
    Motuz LP; Plotnikov AN; Korotkov KV; Alakhov IuB
    Bioorg Khim; 1994; 20(8-9):872-82. PubMed ID: 7826414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomes terminated in vitro are in a tight association with non-phosphorylated elongation factor 2 (eEF-2) and GDP.
    Davydova EK; Malinin NL; Ovchinnikov LP
    Eur J Biochem; 1993 Jul; 215(2):291-6. PubMed ID: 8344297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of native rat liver elongation factor 2.
    Marzouki A; Lavergne JP; Reboud JP; Reboud AM
    FEBS Lett; 1989 Sep; 255(1):72-6. PubMed ID: 2792373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced turnover of the elongation factor EF-1 X ribosome complex after treatment with the protein synthesis inhibitor II from barley seeds.
    Nilsson L; Asano K; Svensson B; Poulsen FM; Nygård O
    Biochim Biophys Acta; 1986 Oct; 868(1):62-70. PubMed ID: 3756169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited hydrolysis of the polypeptide chain elongation factor Tu by trypsin. Isolation and characterization of the polypeptide fragments.
    Arai K; Nakamura S; Arai T; Kawakita M; Kaziro Y
    J Biochem; 1976 Jan; 79(1):69-83. PubMed ID: 939763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biosynthesis and conformational state of 17-kDa and 27-kDa N-terminal fragments of elongation factor EF-2 in solution].
    Plotnikov AN; Vasilenko KS; Kirkitadze MD; Kotova NV; Motuz LP; Korotkov KV; Semisotnov GV; Alakhov IuB
    Bioorg Khim; 1996 Jul; 22(7):489-502. PubMed ID: 8992954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of phosphorylated elongation factor 2.
    Carlberg U; Nilsson A; Nygård O
    Eur J Biochem; 1990 Aug; 191(3):639-45. PubMed ID: 2390990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eukaryotic polypeptide elongation system and its sensitivity to the inhibitory substances of plant origin.
    Gałasiński W
    Proc Soc Exp Biol Med; 1996 May; 212(1):24-37. PubMed ID: 8618948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H1a subtype presents structural differences compared to other histone H1 subtypes. Evidence for a specific motif in the C-terminal domain.
    Baubichon-Cortay H; Mallet L; Denoroy L; Roux B
    Biochim Biophys Acta; 1992 Jul; 1122(2):167-77. PubMed ID: 1643090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Domain structure analysis of elongation factor-3 from Saccharomyces cerevisiae by limited proteolysis and differential scanning calorimetry.
    Ladror US; Egan DA; Snyder SW; Capobianco JO; Goldman RC; Dorwin SA; Johnson RW; Edalji R; Sarthy AV; McGonigal T; Walter KA; Holzman TF
    Protein Sci; 1998 Dec; 7(12):2595-601. PubMed ID: 9865954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiformity of elongation factor eEF-2 isolated from rat liver cells.
    Gajko A; Gałasiński W; Gindzieński A
    Biochem Biophys Res Commun; 1994 Jul; 202(2):844-9. PubMed ID: 8048957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and N-terminal sequence analysis of pea chloroplast protein synthesis factor EF-G.
    Akkaya MS; Welcsh PL; Wolfe MA; Duerr BK; Becktel WJ; Breitenberger CA
    Arch Biochem Biophys; 1994 Jan; 308(1):109-17. PubMed ID: 8311443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.